Immunoact Review (October 2026)
ImmunoACT delivers India’s leading CAR-T cell therapy for blood cancer treatment, lymphoma treatment, and leukemia care. Learn how indigenous CAR-T advances affordable cancer treatment nationwide.
ImmunoACT delivers India’s leading CAR-T cell therapy for blood cancer treatment, lymphoma treatment, and leukemia care. Learn how indigenous CAR-T advances affordable cancer treatment nationwide.
What is Immunoact's Revenue?
Immunoact's estimated revenue is $28M.
What does Immunoact do?
ImmunoACT delivers India’s leading CAR-T cell therapy for blood cancer treatment, lymphoma treatment, and leukemia care. Learn how indigenous CAR-T advances affordable cancer treatment nationwide.
){kind=small}
Technology detection powered by advanced web analysis
Powered byTechlist.aiStaydomio
Immunomedics
Vettery
Learn about LHH, with our global network of colleagues who bring local knowledge and experience to support millions of people across the full talent lifecycle.More
Livetiles
Sema4
The #1 genomic test, preferred by more than 80% of genetic and pediatric providers1. Delivering precise, fast, and actionable diagnoses.More